These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 31227355)
1. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses. Song S; Li P; Zhang R; Chen J; Lan J; Lin S; Guo G; Xie Z; Jiang S Vaccine; 2019 Jul; 37(31):4364-4369. PubMed ID: 31227355 [TBL] [Abstract][Full Text] [Related]
2. Construction of Recombinant Zhang X; Zhang R; Wang J; Sui N; Xu G; Yan H; Zhu Y; Xie Z; Jiang S Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960225 [TBL] [Abstract][Full Text] [Related]
3. Immune Responses to Orally Administered Recombinant Zhang F; Zhang Z; Li X; Li J; Lv J; Ma Z; Pan L Viruses; 2021 Oct; 13(10):. PubMed ID: 34696469 [TBL] [Abstract][Full Text] [Related]
4. Oral immunization with recombinant hepatitis E virus antigen displayed on the Lactococcus lactis surface enhances ORF2-specific mucosal and systemic immune responses in mice. Gao S; Li D; Liu Y; Zha E; Zhou T; Yue X Int Immunopharmacol; 2015 Jan; 24(1):140-5. PubMed ID: 25445956 [TBL] [Abstract][Full Text] [Related]
5. The immune response to a recombinant Lactococcus lactis oral vaccine against foot-and-mouth disease virus in mice. Liu X; Qi L; Lv J; Zhang Z; Zhou P; Ma Z; Wang Y; Zhang Y; Pan L Biotechnol Lett; 2020 Oct; 42(10):1907-1917. PubMed ID: 32385744 [TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a novel nanobody against duck hepatitis A virus type 1. Xue W; Zhao Q; Li P; Zhang R; Lan J; Wang J; Yang X; Xie Z; Jiang S Virology; 2019 Feb; 528():101-109. PubMed ID: 30590261 [TBL] [Abstract][Full Text] [Related]
7. Construction of a Recombinant Lactococcus lactis Strain Expressing a Variant Porcine Epidemic Diarrhea Virus S1 Gene and Its Immunogenicity Analysis in Mice. Guo M; Yi S; Guo Y; Zhang S; Niu J; Wang K; Hu G Viral Immunol; 2019 Apr; 32(3):144-150. PubMed ID: 30855219 [TBL] [Abstract][Full Text] [Related]
8. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus. Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494 [TBL] [Abstract][Full Text] [Related]
9. Identification of a conserved B-cell epitope on duck hepatitis A type 1 virus VP1 protein. Wu X; Li X; Zhang Q; Wulin S; Bai X; Zhang T; Wang Y; Liu M; Zhang Y PLoS One; 2015; 10(2):e0118041. PubMed ID: 25706372 [TBL] [Abstract][Full Text] [Related]
10. Evidence of VP1 of duck hepatitis A type 1 virus as a target of neutralizing antibodies and involving receptor-binding activity. Li X; Zhao R; Lin W; Li C; Zhang T; Meng F; Liu M; Zhang Y Virus Res; 2017 Jan; 227():240-244. PubMed ID: 27816429 [TBL] [Abstract][Full Text] [Related]
11. Identification of a conserved neutralizing linear B-cell epitope in the VP1 proteins of duck hepatitis A virus type 1 and 3. Zhang R; Zhou G; Xin Y; Chen J; Lin S; Tian Y; Xie Z; Jiang S Vet Microbiol; 2015 Nov; 180(3-4):196-204. PubMed ID: 26427545 [TBL] [Abstract][Full Text] [Related]
12. High yield expression of duck hepatitis A virus VP1 protein in Escherichia coli, and production and characterization of polyclonal antibody. Li C; Chen Z; Meng C; Li L; Liu G J Virol Methods; 2013 Jul; 191(1):69-75. PubMed ID: 23583731 [TBL] [Abstract][Full Text] [Related]
13. Detection, differentiation, and VP1 sequencing of duck hepatitis A virus type 1 and type 3 by a 1-step duplex reverse-transcription PCR assay. Wen XJ; Cheng AC; Wang MS; Jia RY; Zhu DK; Chen S; Liu MF; Liu F; Chen XY Poult Sci; 2014 Sep; 93(9):2184-92. PubMed ID: 25012848 [TBL] [Abstract][Full Text] [Related]
14. Recombinant Lactococcus lactis co-expressing OmpH of an M cell-targeting ligand and IBDV-VP2 protein provide immunological protection in chickens. Liu L; Zhang W; Song Y; Wang W; Zhang Y; Wang T; Li K; Pan Q; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; He G; Wang X; Cui H Vaccine; 2018 Jan; 36(5):729-735. PubMed ID: 29289381 [TBL] [Abstract][Full Text] [Related]
15. Molecular Evolution and Genetic Analysis of the Major Capsid Protein VP1 of Duck Hepatitis A Viruses: Implications for Antigenic Stability. Ma X; Sheng Z; Huang B; Qi L; Li Y; Yu K; Liu C; Qin Z; Wang D; Song M; Li F PLoS One; 2015; 10(7):e0132982. PubMed ID: 26173145 [TBL] [Abstract][Full Text] [Related]
16. Protection against duck hepatitis a virus type 1 conferred by a recombinant avian adeno-associated virus. Wang AP; Liu L; Gu LL; Guo CM; Wu S; Feng Q; Xia WL; Wu Z; Zhu SY Poult Sci; 2019 Jan; 98(1):112-118. PubMed ID: 30053293 [TBL] [Abstract][Full Text] [Related]
17. Recombinant VP1 protein of duck hepatitis virus 1 expressed in Pichia pastoris and its immunogenicity in ducks. Wang C; Li XK; Wu TC; Wang Y; Zhang CJ; Cheng XC; Chen PY Acta Virol; 2014; 58(4):333-9. PubMed ID: 25518714 [TBL] [Abstract][Full Text] [Related]
18. Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies. Roh JH; Kang M Vet Microbiol; 2018 Jun; 219():107-112. PubMed ID: 29778181 [TBL] [Abstract][Full Text] [Related]
19. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein. Taghinezhad-S S; Mohseni AH; Keyvani H; Razavilar V Microb Pathog; 2019 Jan; 126():149-156. PubMed ID: 30391536 [TBL] [Abstract][Full Text] [Related]
20. Protective immune responses in ducklings induced by a suicidal DNA vaccine of the VP1 gene of duck hepatitis virus type 1. Fu Y; Chen Z; Li C; Liu G Vet Microbiol; 2012 Dec; 160(3-4):314-8. PubMed ID: 22819169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]